New: Clinical trial search, funded by the National Cancer InstituteNew: NCI-funded clinical trial search

Can phentermine use be associated with development of osteoporosis?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How do you approach the diagnostic evaluation of osteoporosis in CKD when renal dysfunction limits use of certain tests or biomarkers?

In cases of significant BMD loss without fractures while on long-term denosumab therapy and in the presence of very low bone turnover markers without secondary causes for bone loss, what is best approach: continuing denosumab anyway or switching to a bisphosphonate?

Do you routinely recommend delaying dental extractions in patients who have recently received intravenous bisphosphonate therapy for osteoporosis treatment?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
TrialMatch
Mobile App

Company

About
Careers
Events
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.